Daniel Malone is President & VP +1 at WEST PHARMACEUTICAL SERVICES INC (WST). They have made 6 open-market trades across 1 company since 2013, most recently 2019-04-30.
CIK 0001527326
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WST | 29,020 | $11.9M |
Shares reported on the most recent Form 4, priced at the 2019-05-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WST | SELL | 2019-04-30 | 2019-05-01 | $123.03 | $1.1M | -2.0% | -4.4% | +14.7% |
| WST | SELL | 2018-06-11 | 2018-06-12 | $97.24 | $486K | +2.3% | +1.9% | +18.5% |
| WST | SELL | 2017-05-02 | 2017-05-02 | $93.31 | $770K | +0.5% | +5.3% | -5.6% |
| WST | SELL | 2016-06-02 | 2016-06-02 | $74.95 | $592K | -0.6% | +0.1% | +7.9% |
| WST | SELL | 2015-11-04 | 2015-11-05 | $61.65 | $275K | -5.9% | -2.8% | -4.1% |
| WST | SELL | 2013-11-06 | 2013-11-08 | $46.58 | $173K | -5.9% | -2.8% | -2.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.